| 3TC | Lamivudine |
| ABC | Abacavir |
| AIDS | Acquired immunodeficiency syndrome |
| aOR | adjusted Odds Ratio |
| ART | Antiretroviral therapy |
| ARV | Antiretroviral |
| AZT | Zidovudine |
| CI | Confidence Interval |
| DRC | Democratic Republic of Congo |
| DTG | Dolutegravir |
| EDTA | Ethylene-diamine-tetra-acetic acid |
| EFV | Efavirenz |
| HCFs | Healthcare facilities |
| HIV | Human Immunodeficiency Virus |
| IQR | Interquartile Range |
| LTFU | Loss to follow-up |
| MTCT | Mother-to-child transmission |
| OIs | opportunistic infections |
| OR | Odds Ratio |
| PLHIV | People living with HIV |
| SDGs | Sustainable development goals |
| TDF | Tenofovir |
| UNAIDS | Join United Nations Programme on HIV/AIDS |
| VL | Viral Load |
| WHO | World Health Organization |